ISRG vs NKE: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-16.
Intuitive Surgical, Inc. Β· Healthcare
$388.97
+45.0% upside to fair value
Grade B High Quality
VS
NIKE, Inc. Β· Consumer Cyclical
$41.05
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NKE trades at a lower forward P/E (19.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG NKE
Current Price $388.97 $41.05
Fair Value Estimate $564.01 $59.52
Upside to Fair Value +45.0% +45.0%
Market Cap $137.8B $60.7B
Forward P/E 46.5x 19.6x
EV / EBITDA 31.4x 14.2x
Price / Sales 13.0x 1.3x
Price / FCF 48.6x 57.9x
Revenue Growth YoY +23.0% -1.1%
Gross Margin 66.3% 42.9%
Operating Margin 30.5% 8.2%
Return on Equity 17.0% 22.0%
Dividend Yield 0% 0%
FCF Yield 2.06% 1.73%
Analyst Consensus Strong Buy Hold
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
NKE β€” NIKE, Inc.
NIKE, Inc. is a leading global athletic footwear and apparel company with a durable competitive moat supported by its strong brand, scale, and global distribution infrastructure. The company is currently led by CEO Elliott Hill, a seasoned Nike veteran who returned in October 2024 to navigate intensifying competition and channel complexity. Despite its market leadership and solid profitability me…
Accumulation Zones
Metric ISRG NKE
Zone Low $423.01 $44.64
Zone High $479.41 $50.59
In Buy Zone? Yes Yes
← ISRG Research    NKE Research β†’    All Research